Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

China Pharma

1.83
+0.09005.18%
Post-market: 1.880.0540+2.96%19:59 EDT
Volume:36.58K
Turnover:65.84K
Market Cap:5.96M
PE:-0.89
High:1.87
Open:1.73
Low:1.70
Close:1.74
Loading ...
OverviewCompanyNewsFilings

North China Pharmaceutical Registers Ceftazidime and Avibactam Sodium for Injection

MT Newswires Live
·
11 Jun

North China Pharmaceutical Gets Registration Certificate for Isavuconazonium Sulfate for Injection

MT Newswires Live
·
06 Jun

North China Pharmaceutical Signs Financial Services Deal With Jizhong Energy Group Finance

MT Newswires Live
·
22 May

US Stock Futures Slump Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern

Benzinga
·
07 Apr

Levi Strauss, Dave & Buster's Entertainment And 3 Stocks To Watch Heading Into Monday

Benzinga
·
07 Apr

China Pharma Holdings Announces Reverse Stock Split

TIPRANKS
·
05 Apr

BRIEF-China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split

Reuters
·
05 Apr

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

THOMSON REUTERS
·
05 Apr

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

PR Newswire
·
05 Apr

North China Pharmaceutical Secures EU GMP Certification

MT Newswires Live
·
13 Mar

North China Pharmaceutical Subsidiary Passes GMP Compliance Inspection

MT Newswires Live
·
25 Feb

Shyndec Pharma Gets China Pharmaceutical Ingredient Approval for Anaesthesia Supplementary Drug

MT Newswires Live
·
08 Jan

Analyst Rate

 
 
 
 

Corporate Actions

Split&Reverse Split
Apr 15, 2025 10 for 1
Split&Reverse Split
Mar 06, 2024 5 for 1
Split&Reverse Split
Mar 06, 2023 10 for 1
Financial Report Announcement
Aug 13, 2021
Financial Report Announcement
May 14, 2021

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.24
Current
-2.83
Sector Average
52.08%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.24
Maximum
-0.35
+1 STD
0.37
Minimum
-14.92
-1 STD
-6.03
Average
-2.83

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.